Global Vascular Embolization Devices Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Johnson & Johnson Services Inc. | Technavio
LONDON--(BUSINESS WIRE)--Nov 21, 2019--
The global vascular embolization devices is poised to grow by USD 1 billion during 2020-2024 at a CAGR of close to 6% during the forecast period. Request Free Sample Pages
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191121005771/en/
Technavio has announced its latest market research report titled global vascular embolization devices market 2020-2024. (Graphic: Business Wire)
Read the 153-page research report with TOC on “Vascular Embolization Devices Market Analysis Report by Product (Coiling and Non-coiling devices), by Geography (Asia, Europe, North America, and ROW), and Segment Forecasts, 2020 - 2024”.
The market is driven by the rising number of new product launches. In addition, the innovations in embolization products and procedures are anticipated to further boost the growth of the vascular embolization devices market.
Healthcare equipment manufacturers are exploring the potential opportunities to convert the increased demand for medical devices into a continuous cycle of innovation and improvisation for enhanced products. Vendors in the market are launching an array of new product lines to offer better options to buyers. In addition, key players in the market are developing new coils with various technological innovations. Thus, increasing product launches coupled with rising technological innovations in the device designing process are expected to drive the vascular embolization devices market during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Vascular Embolization Devices Market Companies:
Abbott Laboratories is headquartered in the US and operates the business under various segments including Established pharmaceuticals, Nutritionals, Diagnostics, and Cardiovascular and neuromodulation. In September 2019, company received FDA approval for Proclaim XR recharge-free neurostimulation system. The company offers AMPLATZER vascular plug, an embolization plug, which is indicated for arterial and venous embolization in the peripheral vasculature.
Boston Scientific Corp.
Boston Scientific Corp. is headquartered in the US and operates under several business segments including MedSurg, Rhythm and Neuro, and Cardiovascular. In August 2019, the company received the US FDA approval for its ImageReady MRI labeling for the Vercise Gevia Deep Brain Stimulation (DBS) System. The company’s key offerings for the vascular embolization devices market are Pushable 0.018 coils and Direxion.
Cook Group is headquartered in the US and has business operations under various business segments, namely Medical devices, Life sciences, Services, Property management, and Resorts. In March 2019, the company launched ProFusion Therapeutic Infusion Needle used for intramuscular or subdermal infusion of therapeutic agents. The device is now available in the United States and Canada. The company’s key offerings the vascular embolization devices market are Retracta detachable embolization coil, Nester embolization coil, and Tornado embolization coil.
Johnson & Johnson Services Inc.
Johnson & Johnson Services Inc. is headquartered in the US and offers products through the following business segments: Consumer, Pharmaceutical, and Medical Devices. The company offers Galaxy G3 mini, an embolization device, which is intended for endovascular embolization of intracranial aneurysms, other neurovascular abnormalities such as arteriovenous malformations, and arteriovenous fistulae.
Medtronic Plc is headquartered in Ireland and offers products through the following business segments: Cardiac and vascular group, Minimally invasive therapies group, Restorative therapies group, and Diabetes group. The company’s key offerings include Pipeline flex embolization device, MVP micro vascular plug system, and Axium detachable coils.
Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform
Vascular Embolization Product Outlook (Revenue, USD Million, 2020 - 2024)
- Coiling Devices
- Non-coiling Devices
Vascular Embolization Devices Regional Outlook (Revenue, USD Million, 2020 - 2024)
- North America
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.Request a free sample report
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191121005771/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH
SOURCE: Technavio Research
Copyright Business Wire 2019.
PUB: 11/21/2019 10:00 PM/DISC: 11/21/2019 10:00 PM